The Mechanism Underlying the Protective Effects of Tannic Acid Against Isoproterenol-Induced Myocardial Fibrosis in Mice.

cardioprotection isoproterenol myocardial fibrosis nuclear factor κB tannic acid toll-like receptor 4

Journal

Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923

Informations de publication

Date de publication:
2020
Historique:
received: 27 04 2019
accepted: 30 04 2020
entrez: 6 6 2020
pubmed: 6 6 2020
medline: 6 6 2020
Statut: epublish

Résumé

Tannic acid (TA) belongs to a class of complex water-soluble polyphenolic derivatives that show anticarcinogenic, antiinflammatory, antioxidant, and scavenging activities. Here, we investigate the protective effects of TA against isoproterenol (ISO)-induced myocardial fibrosis (MF) in mice. Mice received TA and ISO dosing and were sacrificed 48 h later. The activities of creatine kinase (CK), creatine kinase-MB (CK-MB), lactate dehydrogenase (LDH), and mitochondria enzymes were measured. Cardiac histopathology was done using H&E, Sirius red, and Masson's Trichrome staining. Immunohistochemical staining was applied to indicate changes in B-cell lymphoma-2 (Bcl-2), Bcl-2-associated X protein (Bax), and basic fibroblast growth factor (bFGF) protein expressions in cardiac tissue. RT-PCR was used to measure the expression of atrial and brain natriuretic peptides (ANP and BNP, respectively), c-fos, and c-jun. Western blotting was used to measure the expression of nuclear factor-κB (NF-κB) p65, phosphorylated NF-κB p65), toll-like receptor 4 (TLR4), p38, phosphorylated p38, Bax, Bcl-2, and caspase-3. Compared to the ISO group, the TA group had reduced levels of TLR4, p38, p-p38, NF-κB (p65), p-NF-κB (p-p65), caspase-3, Bax, and Bcl-2, as well as CK, CK-MB, and LDH. These results indicate that TA protects against ISO-induced MF, possibly through its ability to suppress the TLR4-mediated NF-κB signaling pathway.

Identifiants

pubmed: 32499705
doi: 10.3389/fphar.2020.00716
pmc: PMC7242737
doi:

Types de publication

Journal Article

Langues

eng

Pagination

716

Informations de copyright

Copyright © 2020 Ma, Zheng, Du, Han, Zhang, Zhang, Gao, Sun and Chu.

Références

PLoS One. 2015 Dec 01;10(12):e0143797
pubmed: 26625122
Food Chem. 2012 Sep 15;134(2):789-96
pubmed: 23107692
J Mol Cell Cardiol. 2006 Mar;40(3):384-93
pubmed: 16466739
J Am Coll Cardiol. 2000 Dec;36(7):2212-8
pubmed: 11127463
Exp Clin Cardiol. 2003 Winter;8(4):173-83
pubmed: 19649217
Antioxid Redox Signal. 2011 Oct 1;15(7):1895-909
pubmed: 21126202
J Pharmacol Sci. 2016 Jan;130(1):15-23
pubmed: 26810570
Pharmacol Rev. 2009 Jun;61(2):177-97
pubmed: 19474110
J Nutr Sci Vitaminol (Tokyo). 2009 Jun;55(3):223-30
pubmed: 19602830
J Cardiovasc Pharmacol. 2004 Oct;44(4):486-92
pubmed: 15454858
Int Immunopharmacol. 2017 Jun;47:95-105
pubmed: 28376392
Circulation. 2005 May 10;111(18):2319-25
pubmed: 15870116
J Pharm Pharmacol. 2016 Apr;68(4):494-502
pubmed: 26969140
J Biomed Sci. 2010 Mar 05;17:15
pubmed: 20202224
Appl Microbiol. 1964 May;12:204-9
pubmed: 14170956
Transl Res. 2019 Jul;209:138-155
pubmed: 30986384
Planta Med. 1989 Feb;55(1):1-8
pubmed: 2654977
Exp Eye Res. 2007 Apr;84(4):745-52
pubmed: 17303121
Phytother Res. 2016 Mar;30(3):510-6
pubmed: 26762248
Br J Pharmacol. 2015 Dec;172(23):5573-85
pubmed: 25766073
Exp Mol Pathol. 2012 Feb;92(1):97-104
pubmed: 22101259
J Neurosci Res. 2001 May 1;64(3):223-34
pubmed: 11319766
Phytother Res. 2015 Sep;29(9):1295-1303
pubmed: 25989747
Int J Cancer. 1992 May 28;51(3):425-32
pubmed: 1592533
Am J Physiol. 1995 Aug;269(2 Pt 2):H638-47
pubmed: 7653628
Am J Physiol Cell Physiol. 2009 Oct;297(4):C928-34
pubmed: 19625613
J Biol Chem. 2006 Jul 28;281(30):21353-61
pubmed: 16714293
FASEB J. 2008 Mar;22(3):659-61
pubmed: 17942826
Front Pharmacol. 2016 Oct 27;7:392
pubmed: 27833552
Mutagenesis. 1997 Jul;12(4):297-303
pubmed: 9237777
J Mol Cell Cardiol. 1999 Jun;31(6):1289-97
pubmed: 10371703
Planta Med. 1993 Feb;59(1):28-31
pubmed: 8441778
Pharmazie. 2015 Apr;70(4):244-50
pubmed: 26012254
Circ Res. 2014 Jan 31;114(3):565-71
pubmed: 24481846
J Mol Biol. 2008 Jan 18;375(3):637-49
pubmed: 18037434
J Exp Zool A Ecol Genet Physiol. 2012 Jun;317(5):303-10
pubmed: 25363579
Biol Pharm Bull. 2010;33(5):759-67
pubmed: 20460751
Biomed Pharmacother. 2017 Sep;93:1253-1260
pubmed: 28738542
Am J Physiol Heart Circ Physiol. 2003 Jun;284(6):H2263-8
pubmed: 12543632
Biomed Pharmacother. 2017 Sep;93:130-145
pubmed: 28624424
Front Genet. 2013 Oct 30;4:219
pubmed: 24198825
J Atheroscler Thromb. 2014;21(7):629-39
pubmed: 24695021

Auteurs

Donglai Ma (D)

School of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang, China.
Collaborative Innovation Center of Integrative Reproductive Disorders, Hebei University of Chinese Medicine, Shijiazhuang, China.
Hebei Key Laboratory of Integrative Medicine on Liver-Kidney Patterns Hebei University of Chinese Medicine, Shijiazhuang, China.

Bin Zheng (B)

School of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang, China.

Huiru Du (H)

Department of Pharmaceutical Engineering, Hebei Chemical and Pharmaceutical College, Shijiazhuang, China.

Xue Han (X)

School of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang, China.

Xuan Zhang (X)

School of Basic Medicine, Hebei University of Chinese Medicine, Shijiazhuang, China.

Jianping Zhang (J)

School of Basic Medicine, Hebei University of Chinese Medicine, Shijiazhuang, China.

Yonggang Gao (Y)

School of Basic Medicine, Hebei University of Chinese Medicine, Shijiazhuang, China.

Shijiang Sun (S)

Hebei Province Hospital of Chinese Medicine, Affiliated Hospital, Hebei University of Chinese Medicine, Shijiazhuang, China.

Li Chu (L)

School of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang, China.
Hebei Key Laboratory of Integrative Medicine on Liver-Kidney Patterns Hebei University of Chinese Medicine, Shijiazhuang, China.

Classifications MeSH